Call for Papers
Volume 1, Issue 1, November 2024
(Submission Last Date: 30-11-2024)
Journal Title: International Journal of Diversified Research Reports
Starting Year: 2024
Publisher: IJDRR
Publication Frequency: Monthly
Subject/Scope: Multidisciplinary Areas
Publication Format: Online
Contact email: contact@ijdrr.com
Publication Time: 3 Days
Article Publication Fee: WAIVED OFF for all the articles received on or before 30-11-2024
Free e-certificates to authors
Note: Plagiarism of the Submitted Manuscripts must be below 10%
The International Journal of Diversified Research Reports invites manuscript submissions throughout the year. This journal is dedicated to publishing a broad range of research across various subfields in Science, Medicine, Pharmacy, and Engineering. We welcome contributions that encompass theoretical analyses, numerical simulations, and experimental studies. The journal emphasizes work that reflects the latest advancements in areas such as Medicine, Pharmacy, Physics, Chemistry, Biotechnology, Manufacturing, Industrial Instrumentation, and various branches of Engineering, including Computer Science, Civil, Mechanical, Electrical, Electronics, and Chemical Engineering. Interdisciplinary research is highly encouraged. To ensure high publication quality, a double-blind peer review process is employed, where author identities are concealed to promote fairness and objectivity. The journal’s primary focus is on publishing original research articles that contribute significantly to the fields of Science, Medicine, Pharmacy, and Engineering.
October 2024 Research Highlights in Medical Sciences
- Recent medical research highlights advances in Alzheimer’s, cancer, metabolic health, and mental health treatments.
- Alzheimer’s studies reveal a “stealth” stage, allowing potential early intervention.
- The INTERLACE trial for cervical cancer finds that pre-treatment chemotherapy reduces death and recurrence risks by up to 40%.
- In mental health, mindfulness-based approaches are matching traditional anti-anxiety meds in effectiveness.
- Metabolic syndrome management benefits from time-restricted eating, supporting preventive health efforts.
- Finally, cancer prevention research tests anastrozole for high-risk women, reflecting a shift toward chemoprevention and precision medicine